The Oncology Informatics Market Size is valued at 6.06 Billion in 2022 and is predicted to reach 11.81 Billion by the year 2031 at a 7.9 % CAGR during the forecast period for 2023-2031.
Oncology informatics plays a vital role in cancer research and treatment. Different resources, methods, and devices/tools are used in this field to deal with cancer. Oncology informatics is very useful in the process of drug discovery and development. The oncology informatics market is growing due to an increasing number of cancer patients and the rise in the adoption of advanced technologies.
There are multiple factors that drive the oncology informatics market, such as the high prevalence of cancer, rising adoption of advanced technologies (EHRs), medical errors reduction in cancer care, the rising cost of cancer care, various government initiatives for the cancer therapy developments and increase in the awareness of the different types of oncology treatments. However, factors such as the high cost of tools, shortage of medical oncologists, data security concerns, and complex and time-consuming therapy procedures can downscale the growth of the oncology informatics market over the forecast period.
The oncology informatics market has been segmented into Types, End-users, and Regions. The Types segment comprises Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support Systems (CDSS), Drug Discovery and Development Informatics, and Image Analytics. EHR is expected to dominate the market during the forecast period. Oncology image analytics solutions are also expected to grow at the highest CAGR during the forecast period. By End-users, the market is divided into Pharmaceutical Industry, Life Science Industry, Contract Research Organizations (CROs), Academic Institutes and Research Centers, and Others (Hospitals and Other Care Facilities). In terms of revenue, pharmaceutical Industries and life science industries are the major end-users segments of the oncology informatics market. At the regional level, the oncology informatics market can be segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to be the significant market shareholder of this market, followed by Asia-Pacific, Europe, and Rest-of-the-World.
Competitive Landscape
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 6.06 Billion |
| Revenue Forecast In 2031 | USD 11.81 Billion |
| Growth Rate CAGR | CAGR of 7.9 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Types, By End-Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Cerner Corporation, Change Healthcare, Elekta AB, F. Hoffmann-La Roche Ltd, Hologic, Inc., IBM Corporation, Inspirata, Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc., Oncology Analytics, Inc, PerkinElmer, Inc., RELX Group, Sirenas, LLC, UnitedHealth Group, Inc, Varian, Medical Systems, Inc, and Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Types
Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on End-users
Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Region
North America Oncology Informatics Market Revenue (US$ Million) By Country,
Europe Oncology Informatics Market Revenue (US$ Million) By Country,
Asia Pacific Oncology Informatics Market Revenue (US$ Million) By Country,
Latin America Oncology Informatics Market Revenue (US$ Million) By Country,
Middle East & Africa Oncology Informatics Market Revenue (US$ Million) By Country,
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.